Horizon Technology Finance Corporation（简称Horizon Technology Finance）与Monroe Capital宣布联合为医疗科技公司Ossio提供高达5000万美元的信贷融资支持。该信贷额度将用于支持Ossio在骨科生物材料领域的业务扩张与产品创新。
此次融资由两家专业金融机构共同主导，体现了市场对Ossio技术实力与增长潜力的认可。信贷资金的注入将加速Ossio在全球市场的商业化进程，并推动其可吸收骨固定材料技术的临床应用。
作为专注于生命科学领域的融资机构，Horizon Technology Finance长期致力于为高成长性医疗企业提供定制化资本解决方案。而Monroe Capital在中间市场贷款领域拥有丰富经验，双方合作将进一步强化对创新医疗企业的支持力度。
Ossio开发的创新型骨科材料技术，旨在通过可吸收植入物替代传统金属固定装置，为患者提供更优的治疗选择。此次融资将为公司后续研发与市场拓展提供关键资金保障。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.